Search

Your search keyword '"Vij, Ravi"' showing total 36 results

Search Constraints

Start Over You searched for: Author "Vij, Ravi" Remove constraint Author: "Vij, Ravi" Database Springer Nature Journals Remove constraint Database: Springer Nature Journals
36 results on '"Vij, Ravi"'

Search Results

1. IL-10R inhibition reprograms tumor-associated macrophages and reverses drug resistance in multiple myeloma

4. Comprehensive molecular profiling of multiple myeloma identifies refined copy number and expression subtypes

5. Epigenetic regulation during cancer transitions across 11 tumour types

7. Cross center single-cell RNA sequencing study of the immune microenvironment in rapid progressing multiple myeloma

8. Motixafortide and G-CSF to mobilize hematopoietic stem cells for autologous transplantation in multiple myeloma: a randomized phase 3 trial

10. CS1 CAR-T targeting the distal domain of CS1 (SLAMF7) shows efficacy in high tumor burden myeloma model despite fratricide of CD8+CS1 expressing CAR-T cells

11. LocoMMotion: a prospective, non-interventional, multinational study of real-life current standards of care in patients with relapsed and/or refractory multiple myeloma

16. A dose-finding Phase 2 study of single agent isatuximab (anti-CD38 mAb) in relapsed/refractory multiple myeloma

18. Quality of life analyses in patients with multiple myeloma: results from the Selinexor (KPT-330) Treatment of Refractory Myeloma (STORM) phase 2b study

20. Co-evolution of tumor and immune cells during progression of multiple myeloma

23. A phase 2 study of isatuximab monotherapy in patients with multiple myeloma who are refractory to daratumumab

24. Correction: Allogeneic transplantation in elderly patients ≥65 years with non-Hodgkin lymphoma: a time-trend analysis

25. Outcomes of patients with multiple myeloma refractory to CD38-targeted monoclonal antibody therapy

27. Tumor microenvironment-targeted nanoparticles loaded with bortezomib and ROCK inhibitor improve efficacy in multiple myeloma

29. Allogeneic transplantation in elderly patients ≥65 years with non-Hodgkin lymphoma: a time-trend analysis

31. Donor body mass index does not predict graft versus host disease following hematopoietic cell transplantation

33. Similar survival outcomes in patients with biclonal versus monoclonal myeloma: a multi-institutional matched case-control study

34. A multiple myeloma-specific capture sequencing platform discovers novel translocations and frequent, risk-associated point mutations in IGLL5

Catalog

Books, media, physical & digital resources